A Systematic Review of What Barriers and Facilitators Prevent and Enable Physical Healthcare Services Access for Autistic Adults.


Journal

Journal of autism and developmental disorders
ISSN: 1573-3432
Titre abrégé: J Autism Dev Disord
Pays: United States
ID NLM: 7904301

Informations de publication

Date de publication:
Aug 2019
Historique:
pubmed: 28 5 2019
medline: 11 10 2019
entrez: 25 5 2019
Statut: ppublish

Résumé

Autistic people are more likely to: be diagnosed with a range of physical health conditions (i.e. cardio-vascular disease); experience premature mortality (for most disease categories); and experience barriers to effectively accessing healthcare. This systematic review sought to identify studies that report on barriers and facilitators to physical healthcare access for autistic people. A total of 3111 records were screened and six studies were included: two quantitative, two qualitative, and two mixed-methodology studies. Patient-provider communication, sensory sensitivities, and executive functioning/planning issues emerged as important barriers to healthcare. Recommendations for clinicians and those planning services are discussed.

Identifiants

pubmed: 31124030
doi: 10.1007/s10803-019-04049-2
pii: 10.1007/s10803-019-04049-2
pmc: PMC6647496
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

3387-3400

Références

Autism. 2016 Jul;20(5):515-6
pubmed: 27141078
J Intellect Disabil. 2018 Mar;22(1):96-108
pubmed: 27623754
J Autism Dev Disord. 2015 Dec;45(12):4002-14
pubmed: 26334872
J Autism Dev Disord. 2018 Feb;48(2):511-519
pubmed: 29063482
Autism. 2018 Jan;22(1):51-61
pubmed: 28750547
Autism. 2017 Nov;21(8):972-984
pubmed: 27663266
Autism. 2015 Oct;19(7):824-31
pubmed: 25882392
J Gen Intern Med. 2016 Oct;31(10):1180-9
pubmed: 27271730
J Autism Dev Disord. 2001 Feb;31(1):5-17
pubmed: 11439754
J Autism Dev Disord. 2011 May;41(5):566-74
pubmed: 20640591
Neuropsychology. 2006 Jan;20(1):30-41
pubmed: 16460220
BMC Public Health. 2012 Sep 07;12:750
pubmed: 22958354
Curr Opin Psychiatry. 2017 Mar;30(2):69-76
pubmed: 28067726
J Am Acad Child Adolesc Psychiatry. 2012 Apr;51(4):368-83
pubmed: 22449643
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
Trends Cogn Sci. 2002 Nov 1;6(11):455
pubmed: 12457894
JAMA Pediatr. 2016 Mar;170(3):243-50
pubmed: 26752506
J Am Acad Child Adolesc Psychiatry. 2012 Jan;51(1):28-40.e3
pubmed: 22176937
J Autism Dev Disord. 2018 Jan;48(1):36-44
pubmed: 28900771
Disabil Health J. 2017 Apr;10(2):264-270
pubmed: 27899267
Autism. 2009 May;13(3):215-28
pubmed: 19369385
Autism Adulthood. 2019 Mar 1;1(1):27-36
pubmed: 36600693
Pediatr Res. 2011 May;69(5 Pt 2):48R-54R
pubmed: 21289533
Dementia (London). 2019 Oct-Nov;18(7-8):2710-2730
pubmed: 29411662
Arch Psychiatr Nurs. 2016 Oct;30(5):575-80
pubmed: 27654240
J Adolesc Health. 2016 Sep;59(3):345-353
pubmed: 27287962
Autism. 2014 May;18(4):428-32
pubmed: 24085741
J Autism Dev Disord. 2013 Jul;43(7):1555-67
pubmed: 23179340
Br J Psychiatry. 2016 Mar;208(3):232-8
pubmed: 26541693
J Autism Dev Disord. 2012 Oct;42(10):2141-51
pubmed: 22350339
J Autism Dev Disord. 2017 Nov;47(11):3659-3668
pubmed: 28755035
Int J Geriatr Psychiatry. 2012 Feb;27(2):109-18
pubmed: 21538534
Autism. 2015 Oct;19(7):814-23
pubmed: 25911091
J Eval Clin Pract. 2012 Aug;18(4):746-52
pubmed: 21410846
J Autism Dev Disord. 2016 Jun;46(6):1916-1930
pubmed: 26861713
J Gen Intern Med. 2013 Jun;28(6):761-9
pubmed: 23179969
J Autism Dev Disord. 2016 Apr;46(4):1441-54
pubmed: 26762115
Neuropsychology. 2014 Jan;28(1):30-42
pubmed: 24128041
Br J Gen Pract. 2017 Jun;67(659):e445-e452
pubmed: 28483821

Auteurs

David Mason (D)

Institute of Neuroscience, Newcastle University, Sir James Spence Institute level 3, Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, UK. David.Mason@newcastle.ac.uk.

Barry Ingham (B)

Institute of Neuroscience, Newcastle University, Sir James Spence Institute level 3, Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, UK.
Northumberland, Tyne & Wear NHS Foundation Trust, Newcastle upon Tyne, UK.

Anna Urbanowicz (A)

Global, Urban and Social Studies, RMIT University, Melbourne, VIC, Australia.

Cos Michael (C)

, London, UK.

Heather Birtles (H)

Newcastle University, Newcastle upon Tyne, UK.

Marc Woodbury-Smith (M)

Institute of Neuroscience, Newcastle University, Sir James Spence Institute level 3, Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, UK.
Northumberland, Tyne & Wear NHS Foundation Trust, Newcastle upon Tyne, UK.

Toni Brown (T)

Northumberland, Tyne & Wear NHS Foundation Trust, Newcastle upon Tyne, UK.

Ian James (I)

Campus for Ageing and Vitality, Newcastle General Hospital, Newcastle upon Tyne, UK.

Clare Scarlett (C)

NHS North Tyneside CCG, North Shields, UK.

Christina Nicolaidis (C)

Portland State University, Portland, USA.

Jeremy R Parr (JR)

Institute of Neuroscience, Newcastle University, Sir James Spence Institute level 3, Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, UK.
Northumberland, Tyne & Wear NHS Foundation Trust, Newcastle upon Tyne, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH